Irregular
+126%
est. 2Y upside i
Irregular (formerly Pattern Labs) is the first frontier security lab, building defenses that uncover vulnerabilities and secure advanced AI before release.
Rank
#302
Sector
AI Security
Est. Liquidity
~6Y
Data Quality
Data: HighIrregular presents a moderate upside opportunity driven by its pioneering role in the critical and rapidly expanding frontier AI security market.
Last updated: March 10, 2026
Irregular establishes itself as the definitive standard-setter in frontier AI security, leveraging its SOLVE framework and partnerships with leading AI labs to capture significant market share. It successfully commercializes deployable tools, achieving an estimated $2.0B+ valuation by 2031, driven by strong recurring revenue from enterprise and government contracts.
Irregular maintains its strong position in AI security evaluations and research, growing steadily with its core customer base. While commercialization of tools progresses, it faces increased competition, leading to a more modest growth trajectory and an estimated $900M valuation by 2031.
Dominant incumbents or well-funded competitors rapidly develop in-house AI security capabilities or acquire smaller players, commoditizing Irregular's services. Regulatory complexity or slower-than-expected market adoption for deployable tools leads to a down round or acquisition at a significantly reduced valuation, potentially as low as $90M, wiping out most common stock value due to liquidation preferences.
Preference Stack Risk
highFunding Intensity
18%Investors hold $80M in liquidation preferences. In an exit at or below $450M, common stock holders would only see returns after this $80M is paid out to preferred shareholders.
Dilution Risk
moderateAs a Series A company, Irregular will likely require 1-2 more significant funding rounds before a potential IPO or major acquisition, leading to further dilution for existing equity holders.
Secondary Liquidity
noneThere is no public information suggesting an active secondary market or tender offers for Irregular's shares at this stage.
R&D — 7 roles
- AI Researcher · Tel Aviv
- Cyber Researcher · Tel Aviv
- Research Engineer · Tel Aviv
- +4 more →
Strategy and Support — 1 role
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Irregular's data — designed to show you've done your homework.
- 1
“Given that many of your notable customers are also large tech companies with significant R&D budgets, how do you plan to maintain your competitive edge and prevent them from developing similar in-house capabilities or acquiring competitors to move into your space?”
- 2
“With the EU AI Act and various state laws coming into effect, how is Irregular strategically navigating the high regulatory barrier to ensure compliance while also leveraging its role in shaping global AI security standards to its advantage?”
- 3
“As a Series A company, what are the key milestones and metrics the company is focused on achieving in the next 12-24 months to demonstrate progress towards commercializing deployable tools and securing future funding rounds?”
Community
Valuation Sentiment
Our model estimates +126% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.